Multicenter Study

. 2018 Sep 17;8(9):e023265.

doi: 10.1136/bmjopen-2018-023265.

Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration

Jan F Scheitz¹, Henrik Gensicke², Sanne M Zinkstok³, Sami Curtze^{4

5}, Marcel Arnold⁶, Christian Hametner⁷, Alessandro Pezzini⁸, Guillaume Turc⁹, Andrea Zini¹⁰, Visnja Padjen¹¹, Susanne Wegener¹², Annika Nordanstig¹³, Lars Kellert¹⁴, Georg Kägi¹⁵, Yannick Bejot¹⁶, Patrik Michel¹⁷, Didier Leys¹⁸, Christian H Nolte¹, Paul J Nederkoorn³, Stefan T Engelter^{2

19}; TRISP collaboration

Collaborators, Affiliations

Collaborators

TRISP collaboration:
Y Béjot, C Blanc, C Chazalon, B Daubail, B Delpont, M Giroud, M Hervieu-Bègue, G V Osseby, M Bodenant, C Cordonnier, N Dequatre-Ponchelle, H Hénon, D Leys, S Moulin, J L Mas, C Oppenheim, P Seners, G Turc, S Curtze, J Putaala, G Sibolt, D Strbian, T Tatlisumak, J Berrouschot, H Erdur, C H Nolte, J F Scheitz, C Hametner, P Ringleb, L Keller, A Padovani, A Pezzini, G Bigliardi, L Vandelli, M L Dell'acqua, P Nichelli, L Picchetto, S Maffei, A Morotti, A Zini, J M Coutinho, A E D Groot, P J Nederkoorn, Y B Roos, F H M Spaander, Sa Van Den Berg, S M Zinkstok, T P Zonneveld, A Nordanstig, J E Karlsson, C Karlsson, K Jood, T Tatlisumak, L H Bonati, G M De Marchis, S T Engelter, H Gensicke, L Hert, P A Lyrer, N Peters, A Polymeris, C Traenka, D J Seiffge, M Arnold, U Fischer, M R Heldner, H Sarikaya, O Bill, A Eskandari, P Michel, G Kaegi, S Wegener, A R Luft, L Beslac Bumbasirevic, D R Jovanovic, V Padjen, M Stefanovic Budimkic, P Stanarcevic, I Berisavac, M Ercegovac

Affiliations

¹ Department of Neurology and Center for Stroke Research, Charité-Universitätsmedizin Berlin, Berlin, Germany.
² Department of Neurology and Stroke Center, University of Basel and University Hospital Basel, Basel, Switzerland.
³ Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.
⁴ Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
⁵ Department of Neurological Sciences, University of Helsinki, Helsinki, Finland.
⁶ Department of Neurology, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁷ Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
⁸ Department of Clinical and Experimental Sciences, Neurology Clinic, University of Brescia, Brescia, Italy.
⁹ Université Paris Descartes Sorbonne Paris Cité, Centre Hospitalier Sainte-Anne, Paris, France.
¹⁰ Stroke Unit, Department of Neuroscience, Nuovo Ospedale Civile S. Agostino-Estense, University Hospital, Modena, Italy.
¹¹ Neurology Clinic, Clinical Centre of Serbia, Belgrad, Serbia.
¹² Department of Neurology, University of Zürich, Zürich, Switzerland.
¹³ Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
¹⁴ Department of Neurology, Klinikum der Universität München, Ludwig-Maximilians University, München, Germany.
¹⁵ Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
¹⁶ Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon, France.
¹⁷ Department of Neurology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
¹⁸ Department of Neurology, University of Lille, Lille, France.
¹⁹ Neurorehabilitation Unit, University of Basel and University Center for Medicine of Aging and Rehabilitation, Felix Platter Hospital, Basel, Switzerland.

PMID: 30224398
PMCID: PMC6150152
DOI: 10.1136/bmjopen-2018-023265

Multicenter Study

Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration

Jan F Scheitz et al. BMJ Open. 2018.

. 2018 Sep 17;8(9):e023265.

doi: 10.1136/bmjopen-2018-023265.

Authors

Collaborators

TRISP collaboration:
Y Béjot, C Blanc, C Chazalon, B Daubail, B Delpont, M Giroud, M Hervieu-Bègue, G V Osseby, M Bodenant, C Cordonnier, N Dequatre-Ponchelle, H Hénon, D Leys, S Moulin, J L Mas, C Oppenheim, P Seners, G Turc, S Curtze, J Putaala, G Sibolt, D Strbian, T Tatlisumak, J Berrouschot, H Erdur, C H Nolte, J F Scheitz, C Hametner, P Ringleb, L Keller, A Padovani, A Pezzini, G Bigliardi, L Vandelli, M L Dell'acqua, P Nichelli, L Picchetto, S Maffei, A Morotti, A Zini, J M Coutinho, A E D Groot, P J Nederkoorn, Y B Roos, F H M Spaander, Sa Van Den Berg, S M Zinkstok, T P Zonneveld, A Nordanstig, J E Karlsson, C Karlsson, K Jood, T Tatlisumak, L H Bonati, G M De Marchis, S T Engelter, H Gensicke, L Hert, P A Lyrer, N Peters, A Polymeris, C Traenka, D J Seiffge, M Arnold, U Fischer, M R Heldner, H Sarikaya, O Bill, A Eskandari, P Michel, G Kaegi, S Wegener, A R Luft, L Beslac Bumbasirevic, D R Jovanovic, V Padjen, M Stefanovic Budimkic, P Stanarcevic, I Berisavac, M Ercegovac

Affiliations

¹ Department of Neurology and Center for Stroke Research, Charité-Universitätsmedizin Berlin, Berlin, Germany.
² Department of Neurology and Stroke Center, University of Basel and University Hospital Basel, Basel, Switzerland.
³ Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.
⁴ Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
⁵ Department of Neurological Sciences, University of Helsinki, Helsinki, Finland.
⁶ Department of Neurology, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁷ Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
⁸ Department of Clinical and Experimental Sciences, Neurology Clinic, University of Brescia, Brescia, Italy.
⁹ Université Paris Descartes Sorbonne Paris Cité, Centre Hospitalier Sainte-Anne, Paris, France.
¹⁰ Stroke Unit, Department of Neuroscience, Nuovo Ospedale Civile S. Agostino-Estense, University Hospital, Modena, Italy.
¹¹ Neurology Clinic, Clinical Centre of Serbia, Belgrad, Serbia.
¹² Department of Neurology, University of Zürich, Zürich, Switzerland.
¹³ Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
¹⁴ Department of Neurology, Klinikum der Universität München, Ludwig-Maximilians University, München, Germany.
¹⁵ Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
¹⁶ Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon, France.
¹⁷ Department of Neurology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
¹⁸ Department of Neurology, University of Lille, Lille, France.
¹⁹ Neurorehabilitation Unit, University of Basel and University Center for Medicine of Aging and Rehabilitation, Felix Platter Hospital, Basel, Switzerland.

PMID: 30224398
PMCID: PMC6150152
DOI: 10.1136/bmjopen-2018-023265

Abstract

Purpose: The ThRombolysis in Ischemic Stroke Patients (TRISP) collaboration aims to address clinically relevant questions about safety and outcomes of intravenous thrombolysis (IVT) and endovascular thrombectomy. The findings can provide observational information on treatment of patients derived from everyday clinical practice.

Participants: TRISP is an open, investigator-driven collaborative research initiative of European stroke centres with expertise in treatment with revascularisation therapies and maintenance of hospital-based registries. All participating centres made a commitment to prospectively collect data on consecutive patients with stroke treated with IVT using standardised definitions of variables and outcomes, to assure accuracy and completeness of the data and to adapt their local databases to answer novel research questions.

Findings to date: Currently, TRISP comprises 18 centres and registers >10 000 IVT-treated patients. Prior TRISP projects provided evidence on the safety and functional outcome in relevant subgroups of patients who were excluded, under-represented or not specifically addressed in randomised controlled trials (ie, pre-existing disability, cervical artery dissections, stroke mimics, prior statin use), demonstrated deficits in organisation of acute stroke care (ie, IVT during non-working hours, effects of onset-to-door time on onset-to-needle time), evaluated the association between laboratory findings on outcome after IVT and served to develop risk estimation tools for prediction of haemorrhagic complications and functional outcome after IVT.

Future plans: Further TRISP projects to increase knowledge of the effect and safety of revascularisation therapies in acute stroke are ongoing. TRISP welcomes participation and project proposals of further centres fulfilling the outlined requirements. In the future, TRISP will be extended to include patients undergoing endovascular thrombectomy.

Keywords: functional outcome; registry; revascularization; stroke; thrombectomy; thrombolysis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JFS has received speaker honoraria from W L Gore & Associates GmbH and travel support from Bayer and Boehringer-Ingelheim; HG has received research support from the Swiss National Science Foundation; AZ has received funding for speaker honoraria and consulting fees from Boehringer-Ingelheim and Medtronic-Covidien and consulting fees from Nestec; GK received grants from Swiss Parkinson Association, Swiss Heart Association, Swiss National Science Foundation and served on advisory boards for Boehringer-Ingelheim, Bayer, Daiichi Sankyo (Schweiz) AG, Zambon, Nestle, GE Healthcare within the last two years; YB received honoraria or consulting fees from AstraZeneca France, Daiichi-Sankyo, BMS-Pfizer, Covidiem, Bayer and MSD France; PM received research grants from the Swiss National Science Foundation, the Swiss Heart Foundation; speaker fees from Boehringer-Ingelheim, Bayer, Covidien and Stryker; honoraria from scientific advisory boards from Boehringer-Ingelheim, Bayer, Pfizer, Amgen; consulting fees from Pierre-Fabre and Astra-Zeneca; and travel support from Boehringer-Ingelheim and Bayer. All this support is received by the institution (CHUV) and is used for stroke education and research; DL participated during the last 5 years to 1 advisory boards, symposia or trials sponsored by Sanofi Aventis, BMS, Astrazeneca, Boeringher-Ingelheim, Servier, Ebewe, CoLucid Pharm, Brainsgate, Photothera, Lundbeck, GSK, Bayer, Pfizer et Allergan (honorarium paid to Adrinord or research account of the hospital) and was an associated editor of the Journal of neurology, neurosurgery and psychiatry 2004-2010 (personal financial compensation); CHN has received funding for travel or speaker honoraria from Bayer, Boehringer-Ingelheim, Takeda, and BMS/Pfizer; PJN has received consulting fees from Boehringer-Ingelheim; STE has received funding for travel or speaker honoraria from Bayer and Boehringer-Ingelheim, he has served on scientific advisory boards for Bayer, Boehringer-Ingelheim, BMS/Pfizer and Covidien and on the editorial board of Stroke. He has received an educational grant from Pfizer and research support from the Science Funds (Wissenschaftsfonds) of the University Hospital Basel, the University Basel, the Swiss Heart Foundation and the Swiss National Science Foundation.

References

1. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929–35. 10.1016/S0140-6736(14)60584-5 - DOI - PMC - PubMed
1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–8. 10.1056/NEJM199512143332401 - DOI - PubMed
1. Lees KR, Emberson J, Blackwell L, et al. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke 2016;47:2373–9. 10.1161/STROKEAHA.116.013644 - DOI - PMC - PubMed
1. Campbell BC, Meretoja A, Donnan GA, et al. Twenty-year history of the evolution of stroke thrombolysis with intravenous alteplase to reduce long-term disability. Stroke 2015;46:2341–6. 10.1161/STROKEAHA.114.007564 - DOI - PubMed
1. Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2016;47:581–641. 10.1161/STR.0000000000000086 - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration

Collaborators

Affiliations

Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration

Authors

Collaborators

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical